HeartSciences (HSCS) Total Current Liabilities (2022 - 2025)
HeartSciences (HSCS) posted quarterly Total Current Liabilities of $3.7 million for Q4 2025, up 136.42% on a QoQ basis from $1.6 million in Q4 2025.
HeartSciences (HSCS) Total Current Liabilities (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has reported Total Current Liabilities for 4 consecutive years, with $3.7 million the latest figure, recorded in Q4 2025.
- Quarterly Total Current Liabilities changed N/A year-over-year to $3.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.7 million (changed N/A YoY) and the FY2025 annual result came in at $3.7 million, up 111.4% from the prior year.
- Total Current Liabilities rose to $3.7 million in Q4 2025 per HSCS's latest filing, from $1.6 million in the prior quarter.
- Over the last five years, Total Current Liabilities for HSCS reached as high as $3.7 million in Q2 2025 and fell as low as $1.4 million in Q3 2024.
- A 4-year average of $2.6 million and a median of $2.5 million in 2023 frame the typical range for Total Current Liabilities.
- The largest YoY upside for Total Current Liabilities was 123.02% in 2025 against a maximum downside of 52.57% in 2025.
- Year by year, Total Current Liabilities stood at $3.1 million in 2022, then advanced by 12.5% to $3.5 million in 2023, then slipped by 6.47% to $3.3 million in 2024, then gained by 12.13% to $3.7 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $3.7 million, $1.6 million, and $3.0 million for Q4 2025, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.70 Mn |
| Oct 31, 2025 | 1.57 Mn |
| Jul 31, 2025 | 3.01 Mn |
| Apr 30, 2025 | 3.70 Mn |
| Jan 31, 2025 | 3.57 Mn |
| Oct 31, 2024 | 3.30 Mn |
| Jul 31, 2024 | 1.35 Mn |
| Apr 30, 2024 | 1.75 Mn |
| Jan 31, 2024 | 1.71 Mn |
| Oct 31, 2023 | 3.53 Mn |
| Jul 31, 2023 | 1.90 Mn |
| Apr 30, 2023 | 1.83 Mn |
| Jan 31, 2023 | 1.99 Mn |
| Oct 31, 2022 | 3.14 Mn |
| Jul 31, 2022 | 1.54 Mn |
| Apr 30, 2022 | 3.47 Mn |